BRIEF-Xenon Advances Second Proprietary Epilepsy Product Into Clinic With Initiation Of Xen901 Phase 1 Clinical Trial
Feb 20 (Reuters) - Xenon Pharmaceuticals Inc (XENE.O) :
* XENON PHARMACEUTICALS ADVANCES SECOND PROPRIETARY EPILEPSY PRODUCT INTO THE CLINIC WITHINITIATION OF XEN901 PHASE 1 CLINICAL TRIAL
Source text for Eikon: Further company coverage: (XENE.O)
